Home > Insider Trading > Filing (0001209191-22-007126)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806310	Taysha Gene Therapies Inc.	TSHA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494695	B Paul Manning	C/O Taysha Gene Therapies, Inc. 3000 Pegasus Park Drive, Suite 1430 Dallas TX 75247		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-02	58,000	$7.77	92,202	No	4	P	Direct
Common Stock	Acquisiton	2022-02-02	45,000	$7.77	2,065,102	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2022-02-02	22,000	$7.77	22,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2022-02-03	50,000	$7.84	142,202	No	4	P	Direct
Common Stock	Acquisiton	2022-02-03	26,602	$7.84	2,091,704	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Direct
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,195,205	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5).
Shares held by Mr. Manning jointly with his spouse.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
The shares are held directly by BKB G2 Investments LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.725 to $8.00 inclusive.
The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.